ArticleNature communications2026
Unbiased clustering of acute-on-chronic liver failure patients using machine learning in a real-world ICU cohort.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Unbiased clustering of acute-on-chronic liver failure patients using machine learning in a real-world ICU cohort.Nature communications · 2026Article
- A machine learning model for 90-day mortality prediction in hepatitis B virus-related acute-on-chronic liver failure: the pivotal role of CALLY index.Frontiers in medicine · 2026Article
- Dynamic prediction of the development of extrahepatic organ failures in ICU patients with decompensated cirrhosis.eGastroenterology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Acute-on-chronic liver failure is a complex condition with varied definitions, complicating risk stratification and targeted management. We apply unsupervised clustering to data from 1,256 patients with acute-on-chronic liver failure as defined by the North American Association for the Study of End-Stage Liver Disease. We systematically evaluate multiple algorithmic models to enable unbiased cohort stratification and to determine key clustering factors and clinical impacts across clusters. The optimal number of clusters is determined using the Partitioning Around Medoids with Ambiguous Clustering algorithm. The clusters from the best-performing nonnegative matrix factorization algorithm are selected, with the Lee's algorithm demonstrating the best performance. Two distinct clusters are identified, showing markedly different 30-day mortality rates (70.35% vs 26.06%). Importantly, acid-base balance-related variables, including bicarbonate, pH, base excess, lactate, and anion gap, are among the primary clustering drivers. An external validation cohort, a decompensated cirrhosis cohort, and a European Association for the Study of the Liver-Chronic Liver Failure Consortium defined Acute-on-chronic liver failure patients cohort confirm consistent distributions of key clustering variables and divergence in 30-day mortality rates, supporting the role of acid-base balance variables. In summary, we show that the unbiased clustering approach successfully identifies distinct acute-on-chronic liver failure clusters with different mortality risks and emphasizes the critical role of metabolic regulation in acute-on-chronic liver failure outcomes, as well as consistent validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.